Table 2

Uptake/delivery of preventative asthma care by men and women in the two ethnic groups

W/E no (%)ISC no (%)Crude ORMHOR (95% CI)p value
Menn=154n=183
 Previous asthma education105 (68)114 (62)1.311.31 (0.80 to 2.15)0.321
 Advised on trigger factors80 (52)77 (42)1.491.69 (1.05 to 2.75)0.031
 Had symptoms/mechanisms explained79 (51)79 (43)2.452.46 (1.58 to 4.21)<0.001
 Had role of medications explained82 (53)80 (44)1.471.51 (0.95 to 2.43)0.091
 Had drug delivery techniques assessed96 (62)107 (58)1.181.15 (0.71 to 1.87)0.621
 On anti-inflammatory for asthma117 (76)129 (70)1.321.31 (0.77 to 2.28)0.346
 Carries rescue β2 agonists112 (73)104 (57)2.031.69 (1.03 to 2.87)0.039
 Understands role of medications85 (55)81 (44)1.551.41 (0.88 to 2.28)0.165
 Reports full drug compliance112 (73)113 (62)1.651.66 (1.01 to 2.80)0.049
 Owns peak flow meter54 (35)41 (22)1.871.82 (1.09 to 3.09)0.023
 Carries out self management27 (18)21 (11)1.541.41 (0.70 to 2.76)0.404
Womenn=191n=161
 Previous asthma education134 (70)109 (67)1.121.22 (0.75 to 2.01)0.471
 Advised on trigger factors107 (56)67 (42)1.791.99 (1.27 to 3.26)0.003
 Had symptoms/mechanisms explained102 (53)53 (33)2.342.47 (1.57 to 4.03)<0.001
 Had role of medications explained98 (51)78 (48)1.121.22 (0.77 to 1.93)0.438
 Had drug delivery techniques assessed123 (64)99 (61)1.131.24 (0.78 to 1.99)0.404
 On anti-inflammatory for asthma155 (81)128 (80)1.111.12 (0.62 to 2.01)0.795
 Carries rescue β2 agonists161 (84)118 (73)1.962.18 (1.22 to 3.97)0.008
 Understands role of medications112 (59)62 (39)2.262.27 (1.44 to 3.64)<0.001
 Reports full drug compliance142 (74)108 (67)1.421.48 (0.90 to 2.47)0.127
 Owns peak flow meter68 (36)38 (24)1.952.11 (1.27 to 3.61)0.004
 Carries out self management44 (23)20 (12)2.112.17 (1.16 to 4.09)0.014
  • W/E = white European; ISC = Indian subcontinent; MHOR = odds ratio by the Mantel-Haenszel test; CI = Cornfield 95% confidence intervals. p values of <0.05 considered significant (MH χ2 test).